Cargando…
Novel spirocyclic tranylcypromine derivatives as lysine-specific demethylase 1 (LSD1) inhibitors
Herein we describe the design, synthesis, and biological evaluation of a novel series of tranylcypromine-based LSD1 inhibitors via conformational restriction using spiro ring systems. A simple, direct spirocyclic analog of tranylcypromine (compounds 8a and 8b) was shown to be a 28- to 129-fold more...
Autores principales: | Shi, Ying, Wu, Yan-Ran, Su, Ming-Bo, Shen, Dong-Hao, Gunosewoyo, Hendra, Yang, Fan, Li, Jia, Tang, Jie, Zhou, Yu-Bo, Yu, Li-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077246/ https://www.ncbi.nlm.nih.gov/pubmed/35540911 http://dx.doi.org/10.1039/c7ra13097j |
Ejemplares similares
-
Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis
por: Sun, Qunyan, et al.
Publicado: (2016) -
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity
por: Fioravanti, Rossella, et al.
Publicado: (2022) -
Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases
por: Kim, Dongha, et al.
Publicado: (2021) -
Expanding the Role of the Histone Lysine-Specific Demethylase LSD1 in Cancer
por: Majello, Barbara, et al.
Publicado: (2019) -
Lysine-specific histone demethylase 1A (LSD1) in cervical cancer
por: Beilner, Daniel, et al.
Publicado: (2020)